Xerosis Cutis
14
2
2
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
21%
3 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (14)
Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
The Effectiveness of Herbal Creams Compared to Urea in Dry Skin Treatment
Effectiveness of CBD for Neuropathic Pain in Diabetic Foot Neuropathy
A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function Enhancement
Study on the Effectiveness of an Emollient Cream Containing Pre and Postbiotic and Niacinamide 4% in the Treatment of Skin Xerosis and Itching in Oncological Patients Treated with Anti-EGFR
Effectiveness and Safety of Topical Hyaluronic Acid of Different Molecular Weights in Xerotic Skin Treatment
Comparison Dry Foot Skin Between Diabetic and Non-diabetic Subjects and the Effects of Two Cosmetic Foot Care Products
Enhancing SKIN Health and Safety in Aged CARE
Effects of 2% IDL Lotion on Skin Hydration and Transepidermal Water Loss in Females With Dry Skin
Comparison of 12% Ammonium Lactate and 10% Urea Cream in Geriatric With Xerosis Cutis
Effect of Centella Asiatica on Xerotic Skin in Diabetes Mellitus Type 2
Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer in Dry Skin
Skin Health and Effectiveness of Standardized Skin Care Regimens in Nursing Home Residents
Effectiveness of Using an Oil Bath Additive